Patrick D. Yeramian, Chief Medical Officer at Amylyx Pharmaceuticals, Inc. (AMLX), sold 23,930 shares at $29.03 ($695K) on 2023-05-15, disclosed to the SEC on 2023-05-17.
Scheduled sale ($695k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.03 | 11,965 | $347K | 50.0% |
| 2 | $29.03 | 11,965 | $347K | 50.0% |
| Total | $29.03 avg | 23,930 | $695K | 100% |
| Filing → |
| AMLX | SELL | 2023-03-24 | $3.5M | — | Filing → |
| AMLX | SELL | 2023-01-10 | $74K | — | Filing → |